RecruitingNot applicableNCT06962345

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Studying Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mucosa Innovations, S.L.
Principal Investigator
Manuel Albi, MD, PhD
Hospital La Luz
Intervention
Hormone-free vulvovaginal gel with the tested composition XCMIM20m(device)
Enrollment
80 target
Eligibility
40-70 years · FEMALE
Timeline
20242026

Study locations (1)

Collaborators

Hospital de La Luz · Hospital Universitario Fundación Jiménez Díaz

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06962345 on ClinicalTrials.gov

Other trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Additional recruiting or active studies for the same condition.

See all trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

← Back to all trials